Vericel Corp Ord Stock Piotroski F Score
VCEL Stock | USD 34.24 0.62 1.84% |
Vericel | Piotroski F Score |
At this time, it appears that Vericel Corp's Piotroski F Score is Strong. Although some professional money managers and academia have recently criticized Piotroski F-Score model, we still consider it an effective method of predicting the state of the financial strength of any organization that is not predisposed to accounting gimmicks and manipulations. Using this score on the criteria to originate an efficient long-term portfolio can help investors filter out the purely speculative stocks or equities playing fundamental games by manipulating their earnings..
7.0
Piotroski F Score - Strong
1 | Current Return On Assets | Negative | Focus |
2 | Change in Return on Assets | Decreased | Focus |
3 | Cash Flow Return on Assets | Positive | Focus |
4 | Current Quality of Earnings (accrual) | Improving | Focus |
5 | Asset Turnover Growth | Increase | Focus |
6 | Current Ratio Change | Increase | Focus |
7 | Long Term Debt Over Assets Change | Lower Leverage | Focus |
8 | Change In Outstending Shares | Decrease | Focus |
9 | Change in Gross Margin | Increase | Focus |
Vericel Corp Piotroski F Score Drivers
The critical factor to consider when applying the Piotroski F Score to Vericel Corp is to make sure Vericel is not a subject of accounting manipulations and runs a healthy internal audit department. So, if Vericel Corp's auditors report directly to the board (not management), the managers will be reluctant to manipulate simply due to the fear of punishment. On the other hand, the auditors will be free to investigate the ledgers properly because they know that the board has their back. Below are the main accounts that are used in the Piotroski F Score model. By analyzing the historical trends of the mains drivers, investors can determine if Vericel Corp's financial numbers are properly reported.
Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
---|---|---|---|---|---|---|---|---|---|
Weighted Average Shares Diluted | 41.8 M | 47.1 M |
|
| |||||
Weighted Average Shares | 41.7 M | 47.1 M |
|
| |||||
Return on Average Assets | (0.0712) | (0.066) |
|
| |||||
Net Cash Flow from Operations | 19.1 M | 17.7 M |
|
| |||||
Current Liabilities | 40.4 M | 37.5 M |
|
| |||||
Total Liabilities | 87.1 M | 80.7 M |
|
| |||||
Gross Margin | 0.7 | 0.668 |
|
| |||||
Total Debt | 38.3 M | 47.6 M |
|
| |||||
Asset Turnover | 0.82 | 0.653 |
|
| |||||
Current Assets | 201.6 M | 186.9 M |
|
| |||||
Total Assets | 294.6 M | 273 M |
|
|
Vericel Corp Ord F Score Driver Matrix
One of the toughest challenges investors face today is learning how to quickly synthesize historical financial statements and information provided by the company, SEC reporting, and various external parties in order to project the various growth rates. Understanding the correlation between Vericel Corp's different financial indicators related to revenue, expenses, operating profit, and net earnings helps investors identify and prioritize their investing strategies towards Vericel Corp in a much-optimized way.
Click cells to compare fundamentals
About Vericel Corp Piotroski F Score
F-Score is one of many stock grading techniques developed by Joseph Piotroski, a professor of accounting at the Stanford University Graduate School of Business. It was published in 2002 under the paper titled Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers. Piotroski F Score is based on binary analysis strategy in which stocks are given one point for passing 9 very simple fundamental tests, and zero point otherwise. According to Mr. Piotroski's analysis, his F-Score binary model can help to predict the performance of low price-to-book stocks.Book Value per Share |
|
Vericel Corp Current Valuation Drivers
We derive many important indicators used in calculating different scores of Vericel Corp from analyzing Vericel Corp's financial statements. These drivers represent accounts that assess Vericel Corp's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Vericel Corp's important valuation drivers and their relationship over time.
2018 | 2019 | 2020 | 2021 | 2022 | 2023 (projected) | ||
Net Income Per Employee | (37.7K) | (40.1K) | 10.5K | (26.6K) | (54.8K) | (59.1K) | |
Revenue Per Employee | 420.6K | 489.0K | 453.6K | 555.8K | 538.9K | 581.4K | |
Average Assets | 104.4M | 139.5M | 165.0M | 225.3M | 251.5M | 271.4M | |
Earnings Before Interest Taxes and Depreciation Amortization EBITDA | (5.0M) | (5.1M) | 5.4M | (4.6M) | (11.6M) | (12.6M) | |
Earnings Before Interest Taxes and Depreciation Amortization USD | (5.0M) | (5.1M) | 5.4M | (4.6M) | (11.6M) | (12.6M) | |
Earnings before Tax | (8.1M) | (9.7M) | 3.0M | (7.6M) | (16.0M) | (17.3M) | |
Average Equity | 77.1M | 99.9M | 116.7M | 154.6M | 179.4M | 193.5M | |
Enterprise Value | 718.2M | 768.9M | 1.4B | 1.8B | 1.2B | 977.5M | |
Free Cash Flow | (3.1M) | (9.8M) | 14.9M | 21.1M | 10.1M | 10.9M | |
Invested Capital | 85.6M | 134.2M | 202.5M | 199.2M | 224.5M | 242.3M | |
Invested Capital Average | 53.6M | 123.8M | 133.8M | 195.1M | 210.0M | 226.6M | |
Market Capitalization | 754.2M | 777.7M | 1.4B | 1.8B | 1.2B | 995.9M | |
Tangible Asset Value | 118.7M | 153.2M | 205.6M | 243.7M | 265.5M | 286.5M | |
Working Capital | 98.0M | 91.9M | 101.1M | 132.4M | 149.4M | 161.2M |
About Vericel Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vericel Corp Ord's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vericel Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vericel Corp Ord based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts. Vericel operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 281 people.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Vericel Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETF Categories Now
ETF CategoriesList of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
All Next | Launch Module |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Vericel Corp Ord is a strong investment it is important to analyze Vericel Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vericel Corp's future performance. For an informed investment choice regarding Vericel Stock, refer to the following important reports:Check out Vericel Corp Altman Z Score, Vericel Corp Correlation, Vericel Corp Valuation, as well as analyze Vericel Corp Alpha and Beta and Vericel Corp Hype Analysis. Note that the Vericel Corp Ord information on this page should be used as a complementary analysis to other Vericel Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for Vericel Stock analysis
When running Vericel Corp's price analysis, check to measure Vericel Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vericel Corp is operating at the current time. Most of Vericel Corp's value examination focuses on studying past and present price action to predict the probability of Vericel Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vericel Corp's price. Additionally, you may evaluate how the addition of Vericel Corp to your portfolios can decrease your overall portfolio volatility.
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
CEOs Directory Screen CEOs from public companies around the world | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |
Is Vericel Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vericel Corp. If investors know Vericel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vericel Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.343 | Earnings Share (0.21) | Revenue Per Share 3.902 | Quarterly Revenue Growth 0.182 | Return On Assets (0.03) |
The market value of Vericel Corp Ord is measured differently than its book value, which is the value of Vericel that is recorded on the company's balance sheet. Investors also form their own opinion of Vericel Corp's value that differs from its market value or its book value, called intrinsic value, which is Vericel Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vericel Corp's market value can be influenced by many factors that don't directly affect Vericel Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vericel Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vericel Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vericel Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.